Molecule News and Research

RSS

Scientists reverse HIV latency, take major scientific step toward curative therapies

Approximately 38 million people are infected with HIV worldwide, about 1.1 million people in the United States. Currently, people with HIV take antiretroviral therapy (ART), which can suppress HIV to undetectable levels in blood, but the virus persists throughout the body in latently infected resting CD4+ T cells.

22 Jan 2020

New findings can help develop more effective antibiotic treatments to fight superbugs

Researchers have found how an antibiotic used to treat a debilitating gut infection stays put inside the body giving it time to effectively treat the problem, a discovery that will pave the way for the development of more effective antibiotic treatments to fight superbugs.

22 Jan 2020

Holistic Approaches to Psoriasis Treatment

Holistic approaches to psoriasis treatment involves lifestyle advice about weight, smoking, alcohol, sleep, exercise, and other factors.

From J&J Innovative Medicine 22 Jan 2020

New synthetic system can guide electron transfer over long distances

Electrons are tough to pin down in biology. Learning how to harness electrons is no fool's errand because, when electrons move, they are the electricity that powers life.

21 Jan 2020

New method determines the atomic structure of natural products more rapidly, accurately

Many drugs are derived from natural products. But before natural products can be exploited, chemists must first determine their structure and stereochemistry.

21 Jan 2020

International researchers confirm potential inhibitors to combat glioblastoma

After diagnosis, only thirty percent of glioblastoma (an aggressive brain cancer) patients have survived more than two years.

21 Jan 2020

Discovery of potent immune cell that can destroy multiple types of cancer

The immune system is the body’s defense against harmful pathogens that may enter the body. Immune cells, such as white blood cells and macrophages work hand in hand to fight off disease-causing microorganisms, including cancer.

21 Jan 2020

Magnetic nanomaterials may become the basis for new approach to treating liver fibrosis

A team of scientists from Immanuel Kant Baltic Federal University together with their colleagues from NUST MISiS and RWTH Aachen University (Germany) compared different treatments against liver fibrosis and published the results of their study in the Cells journal.

21 Jan 2020

Biophysicists shed light on the structure, functioning mechanism of CysLT receptors

Biophysicists from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases have teamed up with colleagues from Canada, the U.S., Japan, France, and Germany to shed light on the structure and functioning mechanism of the CysLT receptors, which regulate inflammatory responses associated with allergic disorders.

21 Jan 2020

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.

21 Jan 2020

Study finds new strategies for developing cancer drug

After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.

21 Jan 2020

New analysis method shows how the brain regulates its signals using glutamate

Researchers at Chalmers University of Technology and Gothenburg University in Sweden have achieved something long thought almost impossible - counting the molecules of the neurotransmitter glutamate released when a signal is transferred between two brain cells. With a new analysis method, they showed that the brain regulates its signals using glutamate in more ways than previously realised.

21 Jan 2020

Informative white paper demonstrates benefits of novel EAF4 technology

An informative white paper from Postnova Analytics demonstrates how its novel Electrical and Asymmetrical Field Flow Fractionation (EAF4) technology can be used to separate a wide variety of nano-sized materials while simultaneously determining surface charge.

From Postnova Analytics 21 Jan 2020

Lab tests reveal that newly discovered T-cell can kill various types of cancer

Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.

21 Jan 2020

SITESEEKER to be used for Otsuka’s therapeutics discovery programs

PhoreMost will deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER, in disease-relevant pathways nominated by Otsuka.

From PhoreMost 21 Jan 2020

Novel drug inhibits liver damage, obesity and glucose intolerance in mice fed with high-fat diet

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body's glucose balance.

20 Jan 2020

Magnetized molecules help monitor breast cancer

A study published in the journal Proceedings of the National Academy of Sciences reports on a novel type of scanning which uses magnetized molecules to visualize active areas within a breast tumor specifically. This marks the first successful attempt to demonstrate the role of this type of scanning in the field of breast cancer monitoring.

20 Jan 2020

New uses for old medicines

It turns out that in the rush to invent new drugs to treat cancers, scientists may have overlooked some obvious possibilities of existing drugs currently being used for other diseases. A new study says that therapies for diabetes, inflammation and alcoholism, and even for dog arthritis, can also result in the successful killing of cancer cells in culture.

20 Jan 2020

Researchers visualize molecular organization of TNFα receptor molecules

Whether a sick cell dies, divides, or travels through the body is regulated by a sophisticat-ed interplay of signal molecules and receptors on the cell membrane.

17 Jan 2020

Research could be starting point for wound dressings with 'built-in infection stoppers'

Infections are a dreaded threat that can have fatal consequences after an operation, in the treatment of wounds, and during tissue engineering.

17 Jan 2020

Molecule News and Research

Scientists reverse HIV latency, take major scientific step toward curative therapies

New findings can help develop more effective antibiotic treatments to fight superbugs

Holistic Approaches to Psoriasis Treatment

New synthetic system can guide electron transfer over long distances

New method determines the atomic structure of natural products more rapidly, accurately

International researchers confirm potential inhibitors to combat glioblastoma

Discovery of potent immune cell that can destroy multiple types of cancer

Magnetic nanomaterials may become the basis for new approach to treating liver fibrosis

Biophysicists shed light on the structure, functioning mechanism of CysLT receptors

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Study finds new strategies for developing cancer drug

New analysis method shows how the brain regulates its signals using glutamate

Informative white paper demonstrates benefits of novel EAF4 technology

Lab tests reveal that newly discovered T-cell can kill various types of cancer

SITESEEKER to be used for Otsuka’s therapeutics discovery programs

Novel drug inhibits liver damage, obesity and glucose intolerance in mice fed with high-fat diet

Magnetized molecules help monitor breast cancer

New uses for old medicines

Researchers visualize molecular organization of TNFα receptor molecules

Research could be starting point for wound dressings with 'built-in infection stoppers'

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News